FLT4 anticorps

N° du produit ABIN7189520

L’anticorps Lapin Polyclonal anti-FLT4 a été validé pour WB, IHC et ELISA. Il convient pour détecter FLT4 dans des échantillons de Humain.

Aperçu rapide pour FLT4 anticorps (ABIN7189520)

Antigène: FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FLT4 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Détail du produit anti-FLT4 anticorps

Fonction: FLT4 Antibody

Réactivité croisée: Souris, Rat

Purification: The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.

Immunogène: Synthetic peptide from Human protein at AA range: 640-700

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, containing 0.02 % sodium azide as Preservative and 50 % Glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur FLT4

Antigène: FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

Autre désignation: FLT4

Sujet: EC 2.7.10.1 antibody, flt 4 antibody, FLT-4 antibody, FLT4 antibody, FLT41 antibody, Fms related tyrosine kinase 4 antibody, Fms-like tyrosine kinase 4 antibody, LMPH1A antibody, PCL antibody, Soluble VEGFR3 variant 1 antibody, Soluble VEGFR3 variant 2 antibody, Soluble VEGFR3 variant 3 antibody, Tyrosine protein kinase receptor FLT4 antibody, Tyrosine-protein kinase receptor FLT4 antibody, Vascular endothelial growth factor receptor 3 antibody, Vascular endothelial growth factor receptor 3 precursor antibody, VEGF R3 antibody, VEGFR 3 antibody, VEGFR-3 antibody, VEGFR3 antibody, VGFR3_HUMAN antibody

UniProt: P35916

Pathways: Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling